infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-F...

FDA Recall #D-0335-2019 — Class II — November 26, 2018

Recall #D-0335-2019 Date: November 26, 2018 Classification: Class II Status: Terminated

Product Description

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.

Reason for Recall

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Recalling Firm

Tris Pharma Inc. — Monmouth Junction, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

164,304 bottles

Distribution

One distributor in PA who further distributed Nationwide in the USA.

Code Information

Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated